SMAD4 gene mutation and prognosis of pancreatic adenocarcinoma

被引:0
|
作者
Derbel, Olfa [1 ]
de la Fouchardiere, Arnaud [1 ]
Peron, Julien [1 ]
Desseigne, Francoise [1 ]
Heudel, Pierre [1 ]
Guibert, Pierre [1 ]
Rivoire, Michel [1 ]
Meeus, Pierre [1 ]
Peyrat, Patrice [1 ]
Lemaistre, Anne-Isabelle [1 ]
De La Fouchardiere, Christelle [1 ]
机构
[1] Ctr Leon Berard, F-69373 Lyon, France
关键词
D O I
10.1200/jco.2013.31.4_suppl.180
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
180
引用
收藏
页数:1
相关论文
共 50 条
  • [1] The SMAD4 protein and prognosis of pancreatic ductal adenocarcinoma
    Tascilar, M
    Skinner, HG
    Rosty, C
    Sohn, T
    Wilentz, RE
    Offerhaus, GJA
    Adsay, V
    Abrams, RA
    Cameron, JL
    Kern, SE
    Yeo, CJ
    Hruban, RH
    Goggins, M
    CLINICAL CANCER RESEARCH, 2001, 7 (12) : 4115 - 4121
  • [2] SMAD4 Gene Mutations Are Associated with Poor Prognosis in Pancreatic Cancer
    Blackford, Amanda
    Serrano, Oscar K.
    Wolfgang, Christopher L.
    Parmigiani, Giovanni
    Jones, Sian
    Zhang, Xiaosong
    Parsons, D. Williams
    Lin, Jimmy Cheng-Ho
    Leary, Rebecca J.
    Eshleman, James R.
    Goggins, Michael
    Jaffee, Elizabeth M.
    Iacobuzio-Donahue, Christine A.
    Maitra, Anirban
    Cameron, John L.
    Olino, Kelly
    Schulick, Richard
    Winter, Jordan
    Herman, Joseph M.
    Laheru, Daniel
    Klein, Alison P.
    Vogelstein, Bert
    Kinzler, Kenneth W.
    Velculescu, Victor E.
    Hruban, Ralph H.
    CLINICAL CANCER RESEARCH, 2009, 15 (14) : 4674 - 4679
  • [3] SMAD4 Genetic Alterations Predict a Worse Prognosis in Patients With Pancreatic Ductal Adenocarcinoma
    Singh, Puneet
    Srinivasan, Radhika
    Wig, Jai Dev
    PANCREAS, 2012, 41 (04) : 541 - 546
  • [4] The effect of SMAD4 expression on angiogenesis of pancreatic adenocarcinoma
    Schrödel, A.
    Jesnowski, R.
    Molema, I.
    Löhr, M.
    JOURNAL OF VASCULAR RESEARCH, 2006, 43 : 74 - 74
  • [5] SMAD4 deficient pancreatic adenocarcinoma are poor prognosis tumours associated with histopathological aggressive features
    Fenouil, T.
    Caligaris, C.
    Bertrand, A.
    Santis, S.
    Bartholin, L.
    Hervieu, V.
    VIRCHOWS ARCHIV, 2019, 475 : S21 - S21
  • [6] Restoration of SMAD4 by gene therapy reverses the invasive phenotype in pancreatic adenocarcinoma cells
    Duda, DG
    Sunamura, M
    Lefter, LP
    Furukawa, T
    Yokoyama, T
    Yatsuoka, T
    Abe, T
    Inoue, H
    Motoi, F
    Egawa, S
    Matsuno, S
    Horii, A
    ONCOGENE, 2003, 22 (44) : 6857 - 6864
  • [7] Restoration of SMAD4 by gene therapy reverses the invasive phenotype in pancreatic adenocarcinoma cells
    Dan G Duda
    Makoto Sunamura
    Liviu P Lefter
    Toru Furukawa
    Tadaaki Yokoyama
    Toshimasa Yatsuoka
    Tadayoshi Abe
    Hiroko Inoue
    Fuyuhiko Motoi
    Shin-ichi Egawa
    Seiki Matsuno
    Akira Horii
    Oncogene, 2003, 22 : 6857 - 6864
  • [8] Implications of SMAD4 Genetic Status in Recurrent Pancreatic Adenocarcinoma
    AlMasri, S. S.
    Zenati, M.
    Singhi, A. D.
    Lee, K. K.
    Bahary, N.
    Bartlett, D.
    Zureikat, A.
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (SUPPL 1) : S29 - S29
  • [9] SMAD4 and the TGFβ Pathway in Patients with Pancreatic Ductal Adenocarcinoma
    Dardare, Julie
    Witz, Andrea
    Merlin, Jean-Louis
    Gilson, Pauline
    Harle, Alexandre
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (10)
  • [10] New insight into the role of SMAD4 mutation/deficiency in the prognosis and therapeutic resistance of pancreatic ductal adenocarcinomas
    Yao, Hongjuan
    Luo, Liaoxin
    Li, Rui
    Zhao, Yelin
    Zhang, Li
    Pesic, Milica
    Cai, Lin
    Li, Liang
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2024, 1879 (06):